Test
Primary Care Paramedic Medical Directives Version 3.2 ALS
Este test tiene tipos de pregunta que se abren en el reproductor de siempre.
Preguntas del test (41)
1The conditions for salbutamol are:
AGE: N/A
LOA: [blank_start]N/A[blank_end]
HR: [blank_start]N/A[blank_end]
RR: [blank_start]N/A[blank_end]
SBP: N/A
Other: [blank_start]N/A[blank_end]- AN/A
- BN/A
- CN/A
- DN/A
2The contraindications for salbutamol are: [blank_start]Allergy or sensitivity to salbutamol[blank_end]
- AAllergy or sensitivity to salbutamol
3The conditions for epinephrine under the bronchoconstriction directive are:
AGE: N/A
LOA: [blank_start]N/A[blank_end]
HR: [blank_start]N/A[blank_end]
RR: [blank_start]BVM ventilation required[blank_end]
SBP: [blank_start]N/A[blank_end]
Other: [blank_start]Hx of asthma[blank_end]- AN/A
- BN/A
- CBVM ventilation required
- DN/A
- EHx of asthma
4The contraindications for Epinephrine under the Bronchoconstriction Medical Directive are: [blank_start]Allergy or sensitivity to epinephrine[blank_end]
- AAllergy or sensitivity to epinephrine
5Under the Bronchoconstriction Medical Directive Consider Salbutamol:
Weight: <[blank_start]25[blank_end] kg
Route: MDI
Dose: Up to [blank_start]600[blank_end] mcg ([blank_start]6[blank_end] puffs)
Max. Single Dose: [blank_start]600[blank_end] mcg
Dosing interval [blank_start]5[blank_end]-[blank_start]15[blank_end] min. PRN
Max # of doses [blank_start]3[blank_end]- A25
- B30
- C20
- D5
- E600
- F800
- G500
- H700
- I6
- J1
- K4
- L8
- M600
- N800
- O100
- P10000
- Q5
- R3
- S8
- T10
- U15
- V10
- W8
- X20
- Y3
- Z5
- AA7
- AB12
6Under the Bronchoconstriction Medical Directive Consider epinephrine:
Weight: [blank_start]N/A[blank_end]
Route: [blank_start]IM[blank_end]
Concentration: [blank_start]1:1,000[blank_end]
Dose: [blank_start]0.01[blank_end]mg/kg
Max. Single Dose: [blank_start]0.5[blank_end] mg
Dosing interval : [blank_start]N/A[blank_end]
Max # of doses: [blank_start]1[blank_end]- AN/A
- B>25 kg
- C<25 kg
- D>50 kg
- EIM
- FIV
- GPO
- HSC
- I1:1,000
- J1:10,000
- K2:20,000
- L1:10
- M0.01
- N0.05
- O0.5
- P1.0
- Q0.5
- R0.2
- S1.0
- T5.0
- UN/A
- V10 min.
- W3-5 min.
- X5-15 min. PRN
- Y1
- Z2
- AA3
- AB6
7Under the Bronchoconstriction Clinical Considerations:
[blank_start]Epinephrine[blank_end] should be the [blank_start]first[blank_end] drug administered if the patient is [blank_start]apneic[blank_end].
[blank_start]Salbutamol[blank_end] MDI may be administered subsequently using a [blank_start]BVM MDI adapter[blank_end].- AEpinephrine
- Bfirst
- Capneic
- DSalbutamol
- EBVM MDI adapter
8Under the Bronchoconstriction Clinical Considerations:
Nebulizations is contraindicated in patients with a known or suspected [blank_start]fever[blank_end] or in the setting of a declared [blank_start]febrile[blank_end] [blank_start]respiratory[blank_end] [blank_start]illness[blank_end] [blank_start]outbreak[blank_end] by the local [blank_start]medical officer[blank_end] of [blank_start]health[blank_end].- Afever
- Binfection
- Cpnneumonia
- DDNR
- Efebrile
- Fbacterial
- GHIV
- Hwater-based
- Irespiratory
- Jautomimmune
- Kurinary tract
- Lgastrointestinal
- Moral
- Nillness
- Ocontagion
- Pvector
- Qepidemic
- Rpandemic
- Soutbreak
- Tsituation
- Uuprising
- Vpatient
- Wmedical officer
- Xminister
- Yjurisdiction
- ZCollege of Nursing Representative
- AAhealth
- ABOntario
- ACthe Medical Advisory Committee
- ADBase Hospital
9Under the Bronchoconstriction Clinical Considerations:
When administering salbutamol MDI, the rate of administration should be:- A100 mcg every 4 breaths
- B1 puff every breath
- Cgradual, so as not to cause reflux hypokalemia
- D1000 mcg every 6 breaths
10Under the Bronchoconstriction Clinical Considerations:
A [blank_start]spacer[blank_end] should be used when administering salbutamol [blank_start]MDI[blank_end].- Aspacer
- BMDI
11Under the Bronchoconstriction Medical Directive Consider Salbutamol:
Weight: <25 kg
Route: [blank_start]NEB[blank_end]Dose: 2.5 mg
Max. Single Dose: [blank_start]2.5 mg[blank_end]
Dosing interval [blank_start]5-15[blank_end] min. PRN
Max # of doses [blank_start]3[blank_end]- A3
- B5
- C10
- D1
- E5-15
- F4-5
- G2
- H2.5 mg
- I5.0 mg
- J50 mcg
- K5.0 mcg
- LNEB
- MNRB
- NBVM
- OMDI
12The indications for the Moderate to Severe Allergic Reaction Medical Directive:
[blank_start]Exposure[blank_end] to a [blank_start]probable allergen[blank_end]
AND
[blank_start]Signs[blank_end] and/or symptoms of a [blank_start]moderate to severe[blank_end] allergic reaction ([blank_start]including anaphylaxis[blank_end])- AExposure
- Bprobable allergen
- CSigns
- Dmoderate to severe
- Eincluding anaphylaxis
13Conditions for Epinephrine under the Moderate to Severe Allergic Reaction Medical Directive:
AGE: [blank_start]N/A[blank_end]
WEIGHT: N/A
LOA: [blank_start]N/A[blank_end]
HR: [blank_start]N/A[blank_end]
RR: [blank_start]N/A[blank_end]
SBP: N/A
Other: For [blank_start]anaphylaxis only[blank_end]- AN/A
- BN/A
- CN/A
- DN/A
- Eanaphylaxis only
14The ONLY contraindication to giving a pediatric patient IM epinephrine without an autoinjector in the case of anaphylaxis according to the Moderate to Severe Allergic Reaction Medical Directive "contraindications" for Epinephrine is: "Allergy or sensitivity to epinephrine"
- AVerdadero
- BFalso
15Under the Moderate to Severe Allergic Reaction Medical Directive Consider epinephrine:
Weight: [blank_start]N/A[blank_end]
Route: IM
Concentration: 1/[blank_start]1000[blank_end]
Dose: 0.01mg/kg
Max. Single Dose: [blank_start]0.5[blank_end] mg
Dosing interval: N/A
Max # of doses: [blank_start]1[blank_end]- AN/A
- B1000
- C0.5
- D1
16According to the formula for approximate pediatric weight (kg) calculation, a 4 year old child should weigh [blank_start]18[blank_end] kg.
Using this weight, the proper dose of IM epinephrine for this child according to the Moderate to Severe Allergic Reaction Medical Directive for anaphylaxis would be [blank_start]0.18[blank_end] mg which may be rounded to the nearest [blank_start]0.05[blank_end] mg, making the proper dose [blank_start]0.2[blank_end] mg.
According to the Epinephrine 1:1000 IM Dosing Chart on page 24, the dose of epinephrine that would be given to a 4 year old child who weighs 18kg is actually [blank_start]0.15[blank_end] mg.
However, according to the same chart, a child weighing 28 kg should receive a dose of [blank_start]0.3[blank_end] mg.- A18
- B15
- C28
- D20
- E0.18
- F0.28
- G0.5
- H1.8
- I0.05
- J1
- K0.5
- L0.1
- M0.2
- N0.19
- O0.5
- P2.00
- Q0.15
- R0.20
- S0.10
- T0.18
- U0.3
- V0.5
- W0.28
- X0.25
17The two drugs administered under the Moderate to Severe Allergic Reaction Medical Directive are:
- AEpinephrine and Diphenhydramine
- BEpinephrine and Dimenhydrinate
- CEpinephrine and Salbutamol
- DSalbutamol and Benadryl
18Conditions for Diphenhydramine under the Moderate to Severe Allergic Reaction Medical Directive:
AGE: [blank_start]N/A[blank_end]
WEIGHT: ≥[blank_start]25[blank_end]kg
LOA: [blank_start]N/A[blank_end]
HR: N/A
RR: N/A
SBP: N/A
Other: N/A- AN/A
- B25
- CN/A
19Under the Moderate to Severe Allergic Reaction Medical Directive Consider diphenhydramine (if certified and authorized):
Weight: ≥[blank_start]25[blank_end] kg to <[blank_start]50[blank_end] kg
Route: [blank_start]IV[blank_end] or IM
Dose: [blank_start]25[blank_end] mg
Max. Single Dose: [blank_start]25[blank_end] mg
Dosing interval: [blank_start]N/A[blank_end]
Max # of doses: [blank_start]1[blank_end]- A25
- B50
- CIV
- D25
- E25
- FN/A
- G1
20Under the Moderate to Severe Allergic Reaction Medical Directive Consider diphenhydramine (if certified and [blank_start]authorized[blank_end]):
Weight: ≥[blank_start]50[blank_end] kg
Route: [blank_start]IV[blank_end] or IM
Dose: [blank_start]50[blank_end] mg
Max. Single Dose: [blank_start]50[blank_end] mg
Dosing interval: [blank_start]N/A[blank_end]
Max # of doses: [blank_start]1[blank_end]- Aauthorized
- B50
- CIV
- D50
- E50
- FN/A
- G1
21Patch to BHP for authorization to use pediatric auto injector for patients <[blank_start]10[blank_end]kg
- A10
- B5
- C12
- D25
22Epinephrine should be the first drug administered in anaphylaxis.
- AVerdadero
- BFalso
23Under the Croup Medical Directive, the indications are:
[blank_start]Severe[blank_end] r[blank_start]espiratory[blank_end] [blank_start]distress[blank_end]
AND
[blank_start]Stridor[blank_end] [blank_start]at[blank_end] r[blank_start]est[blank_end]
AND
[blank_start]Current[blank_end] history of [blank_start]URTI[blank_end]
AND
B[blank_start]arking[blank_end] [blank_start]cough[blank_end] OR [blank_start]recent[blank_end] history of [blank_start]barking[blank_end] cough- ASevere
- Bespiratory
- Cdistress
- DStridor
- Eat
- Fest
- GCurrent
- HURTI
- Iarking
- Jcough
- Krecent
- Lbarking
24Conditions for Epinephrine under the Croup Medical Directive:
AGE: [blank_start]<8[blank_end]
LOA: [blank_start]N/A[blank_end]
HR: [blank_start]<200[blank_end]/min
RR: [blank_start]N/A[blank_end]
SBP: N/A
Other: N/A- A<8
- B>8
- C≤8
- DN/A
- EN/A
- Funaltered
- Galtered
- H<200
- I60-159
- J≥50
- KNormocardic
- LN/A
- M<10/min
- Nabsent
- Obradypneic
25Number of contraindications listed under the Croup Medical Directive for Epinephrine:
- AOnly one
- B2
- C3
- D5
26You are giving epinephrine to a 6 month old under the croup medical directive. Her weight is 17.7lbs or approximately [blank_start]8[blank_end]kg. The correct dose is [blank_start]2.5[blank_end][blank_start]mg[blank_end] of 1:1,000 concentration epinephrine. You can give [blank_start]1[blank_end] dose and the dosing interval is [blank_start]N/A[blank_end]. The route you use is [blank_start]NEB[blank_end].
- A8
- B9
- C10
- D12
- E2.5
- F0.5
- G0.25
- H5.0
- Img
- Jg
- Kmillequivelents/cm
- LCC/kg
- M0.01
- N/kg
- O1
- Pthe second
- QN/A
- Rq5 mins
- S3-5 mins
- T10-15 mins
- UNEB
- VIM
- WMDI
- XIV
27You are giving epinephrine to a 3 month old under the croup medical directive. Her weight is 8.8lbs or approximately [blank_start]4[blank_end]kg. The correct dose is [blank_start]0.5[blank_end][blank_start]mg[blank_end] of 1:1,000 concentration epinephrine. You can give [blank_start]1[blank_end] dose(s) and the dosing interval is [blank_start]N/A[blank_end]. The route you use is [blank_start]NEB[blank_end].
- A4
- B3
- C5
- D6
- E0.5
- F5
- G0.01
- H2.5
- Img
- Jg
- K/kg
- L/min.
- M1
- N2
- Ounlimited
- PN/A
- Q1-3 mins
- R3-5 mins
- S20 mins
- TNEB
- UMDI
- VIM
- WNRM
28The largest single dose of epinephrine in the PCP medical directives v3.2 is in the [blank_start]croup[blank_end] directive. A Primary Care Paramedic can give [blank_start]5mg[blank_end] of 1:1000 epinephrine to a patient who meets the conditions and is ≥[blank_start]1[blank_end] year(s) old.
- Acroup
- B5mg
- C1
29Match the assessment findings with their point vales according to the Westley Croup Score chart on page 30.
Altered level of consciousness is worth [blank_start]5[blank_end] point(s).
Audible inspiratory stridor with a stethoscope is worth [blank_start]1[blank_end] point(s).
Severely Decreased Air Entry is worth [blank_start]2[blank_end] point(s).
Cyanosis with agitation is worth [blank_start]4[blank_end] point(s)
The highest score possible is [blank_start]17[blank_end] point(s)
The lowest score possible is [blank_start]0[blank_end] point(s)
Moderate croup is considered a score of [blank_start]4-7[blank_end] points
Severe croup is a score of [blank_start]>7[blank_end] points- A5
- B6
- C1
- D2
- E4
- F17
- G19
- H15
- I21
- J0
- K-5
- L-10
- M4-7
- N3-6
- O5-9
- P>7
- Q7-19
- R≥7
- S>8
30Croup is generally the result of a:
- Aviral infection.
- Bbacterial infection.
- Cpneumonia.
- Dgenetic enzyme deficiency.
- Eotherwise benign fungal spore.
31Croup is a(n) [blank_start]upper[blank_end] [blank_start]respiratory[blank_end] [blank_start]infection[blank_end].
- Aupper
- Blower
- Cvesicular
- Desophageal
- Erespiratory
- Fend-expiratory
- Galimentary
- Hglial cellular
- Iinfection
- Jrupture
- Kreflux
- Lforamen
32Croup tends to occur in children aged [blank_start]6[blank_end] months to [blank_start]3[blank_end] years and is most prevalent at the age of [blank_start]2[blank_end] years.
- A6
- B3
- C2
33Generally speaking, patients with [blank_start]moderate[blank_end] to [blank_start]severe[blank_end] croup should be considered for therapy as per the medical directive.
- Amoderate
- Bmild
- Cnew onset
- Dcompensatory
- Esevere
- Fepiglottital
34You are following the croup medical directive for a patient whose stridor is audible without a stethoscope, has no retraction, has somewhat decreased air entry, cyanosis only when agitated and a GCS of 13 (this child is normally GCS 15). According the Westley Croup score, what score does this patient receive?
- A12
- B11
- C10
- D17
- E14
35You are following the croup medical directive for a patient whose stridor is audible with a stethoscope, has severe retraction, has severely decreased air entry, no cyanosis and a GCS of 15. According the Westley Croup score, what score does this patient receive?
- A6
- B7
- C5
- D9
- E10
36Your croup patient has a Westley Croup Score of 7. According to ALS, they would be considered to have:
- Amoderate croup.
- Bsevere croup.
- Cmild croup.
- Dno indication to suspect croup.
37Indications for Continuous Positive Airway Pressure (CPAP) Medical Directive - Auxiliary:
S[blank_start]evere[blank_end] [blank_start]respiratory[blank_end] [blank_start]distress[blank_end]
AND
[blank_start]Signs[blank_end] and/or [blank_start]symptoms[blank_end] of [blank_start]acute[blank_end] [blank_start]pulmonary[blank_end] [blank_start]edema[blank_end] OR [blank_start]COPD[blank_end]- Aevere
- Brespiratory
- Cdistress
- DSigns
- Esymptoms
- Facute
- Gpulmonary
- Hedema
- ICOPD
38Conditions for Continuous Positive Airway Pressure (CPAP) Medical Directive - Auxiliary
AGE: ≥[blank_start]18[blank_end] years
LOA: [blank_start]N/A[blank_end]
HR: [blank_start]N/A[blank_end]
RR: [blank_start]Tachypnea[blank_end]
SBP: [blank_start]Normotension[blank_end]
Other: [blank_start]SpO2[blank_end] <[blank_start]90[blank_end]% or [blank_start]accessory muscle use[blank_end]- A18
- BN/A
- CN/A
- DTachypnea
- ENormotension
- F90
- Gaccessory muscle use
- HSpO2
39Contraindications for CPAP
Asthma [blank_start]exacerbation[blank_end]
Suspected [blank_start]pneumothorax[blank_end]
Unprotected or unstable [blank_start]airway[blank_end]
Major [blank_start]trauma or burns[blank_end] to the [blank_start]head or torso[blank_end]
[blank_start]Trache[blank_end]ostomy
Inability to [blank_start]sit upright[blank_end]
Unable to [blank_start]cooperate[blank_end]- Aexacerbation
- Bwithout prior Hx
- Cwithout relief from nebulized salbutamol
- Dpneumothorax
- Etension pneumothorax
- Fspontaneous hemothorax
- Gairway
- Hmandible
- Icervical spine
- Jtrauma or burns
- Kstroke
- Lextremity deformity
- Mfacial asymmetry
- Nhead or torso
- Oneck and chest
- Plung apices
- QTrache
- Rlaryng
- Sgastr
- Tpharyng
- Usit upright
- Vcommunicate verbally
- Wventilate
- Xposition airway
- Ycooperate
- Zopen mouth
- AAadminister salbutamol
- ABdiagnose cause
40Consider CPAP:
Initial setting [blank_start]5[blank_end] cm H2O or equivalent flow rate of device as per BH direction.
[blank_start]Titration[blank_end] [blank_start]increment[blank_end] [blank_start]2.5[blank_end] cm H2O or equivalent flow rate of device as per BH direction.
[blank_start]Titration[blank_end] [blank_start]interval[blank_end] [blank_start]5[blank_end] [blank_start]min[blank_end].
Max. [blank_start]setting[blank_end] [blank_start]15[blank_end] cm H2O or equivalent flow rate of device as per BH direction- A5
- B2.5
- C3
- D10
- E15
- FTitration
- GAmplitude
- HConcentration
- IAdjustment
- J2.5
- K3
- L5
- M10
- N0.5
- Oincrement
- Plevel
- Qperiod
- Rparameters
- STitration
- TTiming
- UCutoff
- VRest
- Winterval
- Xperiod
- Yzone
- Ztimeframe
- AA5
- AB30
- AC90
- AD15
- AEmin
- AFsecs
- AGhours
- AHbreaths
- AIsetting
- AJsuction
- AKresistance
- ALpower
- AM15
- AN30
- AO45
- AP5
41Under the treatment section of the Continuous Positive Airway Pressure Medical Directive:
Consider increasing FiO2 (if available):
Initial FiO2: [blank_start]50[blank_end]-[blank_start]100[blank_end]%
FiO2 increment (if available on device) SpO2 [blank_start]<92%[blank_end] despite treatment and/or [blank_start]10[blank_end] cm H2O pressure or equivalent flow rate of device as per BH direction.
Max FiO2: [blank_start]100%[blank_end]- A50
- B10
- C25
- D95
- E100
- F20
- G90
- H65
- I<92%
- J≥92%
- K>92%
- L≤92%
- M93%
- N10
- O2.5
- P8
- Q5
- R25
- S100%
- T25lpm
- UN/A
- V94-99%
Información
- Descripción
- Diploma Paramedic Test sobre Primary Care Paramedic Medical Directives Version 3.2 ALS, creado por thecatspyjamaz el 24/02/2016.
- Autor
- thecatspyjamaz
- Idioma
- English
- Visitas
- 141
- Etiquetas
- Valoración
- Aún sin valoraciones Valora este test